Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ovidiu Chioncel

Showing results (1-10 of 281) with videos related to

Pageof 29
Sort By:
European Journal of Heart Failure|October 18, 2024
Reply to 'A clinical classification method with outstanding advantages for quickly identifying hazardous types'Ovidiu Chioncel
European Journal of Heart Failure|September 26, 2022
Morphine in acute pulmonary oedema: a signal of harm but more questions than answersOvidiu Chioncel, Marco Metra
Heart Failure Clinics|October 14, 2015
Characteristics of Intensive Care in Patients Hospitalized for Heart Failure in EuropeOvidiu Chioncel, Alexandre Mebazaa
International Journal of Cardiology|July 30, 2019
Morphine in acute heart failure: Feeling better or living longer?Ovidiu Chioncel, Oscar Miro
European Journal of Preventive Cardiology|May 7, 2024
Prognostic impact of heart failure pharmacotherapies in acute heart failure: strong association in mildly reduced ejection fractionOliviana Geavlete, Ovidiu Chioncel
European Journal of Heart Failure|August 3, 2019
Mid-regional pro-atrial natriuretic peptide for diagnosis of heart failure in non-acute settings: biomarkers plus clinical sense make good senseOvidiu Chioncel, Javed Butler
European Journal of Heart Failure|August 5, 2021
Cardiogenic shock centres for optimal care coordination and improving outcomes in cardiogenic shockOvidiu Chioncel, Marco Metra
International Journal of Cardiology|November 29, 2019
Hyperglycemia and outcomes in acute heart failure - A bittersweet relationshipOvidiu Chioncel, Andrew P Ambrosy
International Journal of Cardiology|December 5, 2020
Improving adherence to guideline-directed medical therapies and outcomes in the developing world: A call to end global inequities in heart failureOvidiu Chioncel, Andrew P Ambrosy
European Journal of Heart Failure|January 10, 2019
Trimethylamine N-oxide and risk of heart failure progression: marker or mediator of diseaseOvidiu Chioncel, Andrew P Ambrosy
Pageof 29

Showing results (1-10 of 281) with videos related to

Sort By:
Pageof 29
European Journal of Heart Failure|October 18, 2024
Reply to 'A clinical classification method with outstanding advantages for quickly identifying hazardous types'Ovidiu Chioncel
European Journal of Heart Failure|September 26, 2022
Morphine in acute pulmonary oedema: a signal of harm but more questions than answersOvidiu Chioncel, Marco Metra
Heart Failure Clinics|October 14, 2015
Characteristics of Intensive Care in Patients Hospitalized for Heart Failure in EuropeOvidiu Chioncel, Alexandre Mebazaa
International Journal of Cardiology|July 30, 2019
Morphine in acute heart failure: Feeling better or living longer?Ovidiu Chioncel, Oscar Miro
European Journal of Preventive Cardiology|May 7, 2024
Prognostic impact of heart failure pharmacotherapies in acute heart failure: strong association in mildly reduced ejection fractionOliviana Geavlete, Ovidiu Chioncel
European Journal of Heart Failure|August 3, 2019
Mid-regional pro-atrial natriuretic peptide for diagnosis of heart failure in non-acute settings: biomarkers plus clinical sense make good senseOvidiu Chioncel, Javed Butler
European Journal of Heart Failure|August 5, 2021
Cardiogenic shock centres for optimal care coordination and improving outcomes in cardiogenic shockOvidiu Chioncel, Marco Metra
International Journal of Cardiology|November 29, 2019
Hyperglycemia and outcomes in acute heart failure - A bittersweet relationshipOvidiu Chioncel, Andrew P Ambrosy
International Journal of Cardiology|December 5, 2020
Improving adherence to guideline-directed medical therapies and outcomes in the developing world: A call to end global inequities in heart failureOvidiu Chioncel, Andrew P Ambrosy
European Journal of Heart Failure|January 10, 2019
Trimethylamine N-oxide and risk of heart failure progression: marker or mediator of diseaseOvidiu Chioncel, Andrew P Ambrosy
Pageof 29